Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1364.5 (Glytoucan)

Id:49581b0a-b3ac-5d47-8439-42e034403f2d

Glytoucan:G32747TK

Results found

Linked to

	Label	Description
	1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G06347VR-GLYCOSEQ00088141 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G79436QA-GLYCOSEQ00022491 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G33340GX-GLYCOSEQ00127940 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G50340QI-GLYCOSEQ00088718 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G28477UY-GLYCOSEQ00057546 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G78262KC-GLYCOSEQ00097280 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G58990QD-GLYCOSEQ00021919 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G50622EF-GLYCOSEQ00049837 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G66892DM-GLYCOSEQ00184999 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1364.5 has motif a-Gal antigen Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G06347VR-GLYCOSEQ00088141 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G79436QA-GLYCOSEQ00022491 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G33340GX-GLYCOSEQ00127940 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G50340QI-GLYCOSEQ00088718 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G28477UY-GLYCOSEQ00057546 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G78262KC-GLYCOSEQ00097280 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G58990QD-GLYCOSEQ00021919 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G50622EF-GLYCOSEQ00049837 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1364.5 has glycosequence GLYGEN.GLYCOSEQUENCE:G66892DM-GLYCOSEQ00184999 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1364.5 has motif a-Gal antigen

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.